Stock Analysis

Theragen EtexLtd's (KOSDAQ:066700) Solid Profits Have Weak Fundamentals

KOSDAQ:A066700
Source: Shutterstock

Theragen Etex Co.,Ltd.'s (KOSDAQ:066700) stock was strong after they recently reported robust earnings. However, our analysis suggests that shareholders may be missing some factors that indicate the earnings result was not as good as it looked.

See our latest analysis for Theragen EtexLtd

earnings-and-revenue-history
KOSDAQ:A066700 Earnings and Revenue History March 27th 2024

How Do Unusual Items Influence Profit?

To properly understand Theragen EtexLtd's profit results, we need to consider the ₩22b gain attributed to unusual items. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. Which is hardly surprising, given the name. We can see that Theragen EtexLtd's positive unusual items were quite significant relative to its profit in the year to December 2023. All else being equal, this would likely have the effect of making the statutory profit a poor guide to underlying earnings power.

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Theragen EtexLtd.

Our Take On Theragen EtexLtd's Profit Performance

As we discussed above, we think the significant positive unusual item makes Theragen EtexLtd's earnings a poor guide to its underlying profitability. As a result, we think it may well be the case that Theragen EtexLtd's underlying earnings power is lower than its statutory profit. The silver lining is that its EPS growth over the last year has been really wonderful, even if it's not a perfect measure. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. So while earnings quality is important, it's equally important to consider the risks facing Theragen EtexLtd at this point in time. For example, we've discovered 1 warning sign that you should run your eye over to get a better picture of Theragen EtexLtd.

Today we've zoomed in on a single data point to better understand the nature of Theragen EtexLtd's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

Valuation is complex, but we're helping make it simple.

Find out whether Theragen EtexLtd is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.